Patents by Inventor Christopher D'amato

Christopher D'amato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11827936
    Abstract: This disclosure provides methods and systems for single-cell analysis, including single-cell transcriptome analysis, of target cells without microfluidic devices. The disclosed methods involve the use of template particles to template the formation of monodisperse droplets to generally capture a single target cell from a population of cells in an encapsulation, derive a plurality of distinct mRNA molecules from the single target cell, and quantify the distinct mRNA molecules to generate an expression profile.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: November 28, 2023
    Assignee: Fluent Biosciences Inc.
    Inventors: Kristina Fontanez, Robert Meltzer, Yi Xue, Christopher D'amato, Sepehr Kiani
  • Publication number: 20220403472
    Abstract: This invention provides methods for near-instantaneously separating cells that have undergone RNA guided genome modifications into pre-templated instant partitions (PIPs) and using the PIPs to associate the guide RNAs with the gene expression level changes that resulted from the genome modification.
    Type: Application
    Filed: May 18, 2022
    Publication date: December 22, 2022
    Inventors: Kristina Fontanez, Iain Clark, Christopher D'Amato, Catherine Kugler, Robert Meltzer
  • Publication number: 20220372470
    Abstract: The invention provides high-throughput systems and methods for screening CRISPR-edited cells in bulk with single cell resolution. Methods of the invention use cells expressing polyadenylated guide RNAs that are detectable by RNA sequencing. Methods of the invention provide for the detection of each cell's guide RNA along with its single cell transcriptome to provide useful gene expression data for assessing CRISPR activity from cells in bulk. In addition, methods of the invention offer a high throughput single cell analytical framework for generating single cell transcriptome data from which CRISPR activity may be evaluated.
    Type: Application
    Filed: May 18, 2022
    Publication date: November 24, 2022
    Inventors: Kristina Fontanez, Christopher D'amato, Iain Clark
  • Publication number: 20220267761
    Abstract: Methods to emulsify cells and/or mRNA with reverse transcriptase at a temperature such that the reverse transcriptase begins making cDNA during the emulsification
    Type: Application
    Filed: May 10, 2022
    Publication date: August 25, 2022
    Inventors: Kristina Fontanez, Robert Meltzer, Yi Xue, Christopher D'amato, Sepehr Kiani
  • Publication number: 20220235416
    Abstract: This disclosure provides methods and systems for single-cell analysis, including single-cell transcriptome analysis, of target cells without microfluidic devices. The disclosed methods involve the use of template particles to template the formation of monodisperse droplets to generally capture a single target cell from a population of cells in an encapsulation, derive a plurality of distinct mRNA molecules from the single target cell, and quantify the distinct mRNA molecules to generate an expression profile.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 28, 2022
    Inventors: Kristina Fontanez, Robert Meltzer, Yi Xue, Christopher D'amato, Sepehr Kiani
  • Publication number: 20210214792
    Abstract: This disclosure provides methods and systems for single-cell analysis, including single-cell transcriptome analysis, of target cells without microfluidic devices. The disclosed methods involve the use of template particles to template the formation of monodisperse droplets to generally capture a single target cell from a population of cells in an encapsulation, derive a plurality of distinct mRNA molecules from the single target cell, and quantify the distinct mRNA molecules to generate an expression profile.
    Type: Application
    Filed: January 12, 2021
    Publication date: July 15, 2021
    Inventors: Kristina Fontanez, Robert Meltzer, Yi Xue, Christopher D'amato, Sepehr Kiani
  • Publication number: 20210214721
    Abstract: Methods to emulsify cells and/or mRNA with reverse transcriptase at a temperature such that the reverse transcriptase begins making cDNA during the emulsification
    Type: Application
    Filed: January 12, 2021
    Publication date: July 15, 2021
    Inventors: Kristina Fontanez, Robert Meltzer, Yi Xue, Christopher D'amato, Sepehr Kiani